Gene therapy has emerged as a revolutionary approach to treating genetic disorders by delivering therapeutic genetic material directly into patients' cells. Among the various vectors used for gene delivery, Adeno-Associated Virus (AAV) vectors have gained significant attention due to their safety
The landscape of Alzheimer’s disease (AD) diagnosis and treatment is undergoing a significant transformation thanks to the groundbreaking Simoa® technology by Quanterix. This ultra-sensitive immunoassay platform is reshaping how biomarkers are identified and validated, offering new possibilities
Cancer research has entered a new era with the advent of patient-derived organoids (PDOs). These sophisticated three-dimensional (3D) models, grown from patient cells, have revolutionized our understanding of tumors and their microenvironments. By mimicking the complexity of human tumors, PDOs have
AstraZeneca has recently submitted a Biologics License Application (BLA) to the FDA for datopotamab deruxtecan (Dato-DXd), targeting accelerated approval for adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) that possess EGFR mutations. This submission is a significant
The quest for faster and more efficient protein structure prediction has taken a significant leap forward with the advent of MassiveFold, a new iteration of AlphaFold designed for parallel processing. Within the realm of molecular biology and drug discovery, the speed and accuracy of protein
A groundbreaking study published in The Lancet has revealed promising results for the use of stem-cell-derived corneal implants in restoring vision for patients suffering from limbal stem cell deficiency (LSCD). This condition, which leads to significant vision impairment due to the loss of corneal
